Related references
Note: Only part of the references are listed.First human dose escalation study in patients with metastatic malignancies to determine safety and pharmacokinetics of LY2157299, a small molecule inhibitor of the transforming growth factor-beta receptor I kinase
E. Calvo-Aller et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Down-Regulation of FXYD3 Is Induced by Transforming Growth Factor-β Signaling via ZEB1/δEF1 in Human Mammary Epithelial Cells
Hiroto Yamamoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
SFRP1 reduction results in an increased sensitivity to TGF-β signaling
Kelly J. Gauger et al.
BMC CANCER (2011)
TGF-β Promotion of Gli2-Induced Expression of Parathyroid Hormone-Related Protein, an Important Osteolytic Factor in Bone Metastasis, Is Independent of Canonical Hedgehog Signaling
Rachelle W. Johnson et al.
CANCER RESEARCH (2011)
The Cain and Abl of Epithelial-Mesenchymal Transition and Transforming Growth Factor-beta in Mammary Epithelial Cells
Tressa M. Allington et al.
CELLS TISSUES ORGANS (2011)
Switching TGFβ from a tumor suppressor to a tumor promoter
Gareth J. Inman
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Breast cancer stem cells: A new challenge for breast cancer treatment
Prachi Jain et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Autocrine TGF-beta protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim
Yukari Hoshino et al.
JOURNAL OF BIOCHEMISTRY (2011)
The dynamic roles of TGF-beta in cancer
Erik Meulmeester et al.
JOURNAL OF PATHOLOGY (2011)
CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion
Y. He et al.
ONCOGENE (2011)
Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression
Caitlin D. May et al.
BREAST CANCER RESEARCH (2011)
Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-β-mediated cancer cell invasiveness
Isao Matsuura et al.
BIOCHEMICAL JOURNAL (2010)
More than an accessory: implications of type III transforming growth factor-β receptor loss in prostate cancer
Seun Ajiboye et al.
BJU INTERNATIONAL (2010)
Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics
Jonine D. Figueroa et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands
Matthias B. Stope et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice
Fuminori Abe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Cathepsin G-mediated enhanced TGF-β signaling promotes angiogenesis via upregulation of VEGF and MCP-1
Thomas J. Wilson et al.
CANCER LETTERS (2010)
Matrix Metalloproteinase (MMP)-13 Regulates Mammary Tumor-Induced Osteolysis by Activating MMP9 and Transforming Growth Factor-β Signaling at the Tumor-Bone Interface
Kalyan C. Nannuru et al.
CANCER RESEARCH (2010)
Antiestrogens Induce Transforming Growth Factor β-Mediated Immunosuppression in Breast Cancer
Christian M. Joffroy et al.
CANCER RESEARCH (2010)
Tetraspanin CD151 Regulates Transforming Growth Factor β Signaling: Implication in Tumor Metastasis
Rafal Sadej et al.
CANCER RESEARCH (2010)
Transforming Growth Factor-β (TGF-β)-Inducible Gene TMEPAI Converts TGF-β from a Tumor Suppressor to a Tumor Promoter in Breast Cancer
Prajjal K. Singha et al.
CANCER RESEARCH (2010)
Homeoprotein Six1 Increases TGF-β Type I Receptor and Converts TGF-β Signaling from Suppressive to Supportive for Tumor Growth
Douglas S. Micalizzi et al.
CANCER RESEARCH (2010)
The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling
Jason D. Lee et al.
CARCINOGENESIS (2010)
TGF-β Pathway as a Therapeutic Target in Bone Metastases
Patricia Juarez et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect
Amit Joshi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
Systemic Delivery of an Oncolytic Adenovirus Expressing Soluble Transforming Growth Factor-β Receptor II-Fc Fusion Protein Can Inhibit Breast Cancer Bone Metastasis in a Mouse Model
Zebin Hu et al.
HUMAN GENE THERAPY (2010)
Cellular and molecular basis for the regulation of inflammation by TGF-beta
Akihiko Yoshimura et al.
JOURNAL OF BIOCHEMISTRY (2010)
Sequential Activation of NFAT and c-Myc Transcription Factors Mediates the TGF-β Switch from a Suppressor to a Promoter of Cancer Cell Proliferation
Garima Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
ATF3, an adaptive-response gene, enhances TGFβ signaling and cancer-initiating cell features in breast cancer cells
Xin Yin et al.
JOURNAL OF CELL SCIENCE (2010)
TGF-beta 1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer
Shinako Araki et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Transforming growth factor-beta: A target for cancer therapy
Ronan J. Kelly et al.
JOURNAL OF IMMUNOTOXICOLOGY (2010)
Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer
Tony Blick et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis
Vidya Ganapathy et al.
MOLECULAR CANCER (2010)
Context-Dependent Bidirectional Regulation of the MutS Homolog 2 by Transforming Growth Factor β Contributes to Chemoresistance in Breast Cancer Cells
Yang Yu et al.
MOLECULAR CANCER RESEARCH (2010)
Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies
A. E. G. Lenferink et al.
ONCOGENE (2010)
Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
M. K. Wendt et al.
ONCOGENE (2010)
Transient Tumor-Fibroblast Interactions Increase Tumor Cell Malignancy by a TGF-β Mediated Mechanism in a Mouse Xenograft Model of Breast Cancer
Christina H. Stuelten et al.
PLOS ONE (2010)
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
Joseph H. Taube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
Yasushi Kojima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression
Li Yang et al.
TRENDS IN IMMUNOLOGY (2010)
Downregulation of transforming growth factor β (TGFβ) and latent TGFβ binding protein (LTBP)-4 expression in late stage canine mammary tumours
R. Klopfleisch et al.
VETERINARY JOURNAL (2010)
TGFβ signalling: a complex web in cancer progression
Hiroaki Ikushima et al.
NATURE REVIEWS CANCER (2010)
Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis
L. A. Henry et al.
BREAST CANCER RESEARCH (2010)
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells
Joshua A. Bauer et al.
BREAST CANCER RESEARCH (2010)
Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Antoinette R. Tan et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Transforming Growth Factor β Induces Clustering of HER2 and Integrins by Activating Src-Focal Adhesion Kinase and Receptor Association to the Cytoskeleton
Shizhen Emily Wang et al.
CANCER RESEARCH (2009)
Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation
Mitsuru Futakuchi et al.
CANCER SCIENCE (2009)
The type III transforming growth factor-β receptor negatively regulates nuclear factor kappa B signaling through its interaction with β-arrestin2
Hye Jin You et al.
CARCINOGENESIS (2009)
Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition
Carl-Henrik Heldin et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Activated Abl kinase inhibits oncogenic transforming growth factor-β signaling and tumorigenesis in mammary tumors
Tressa M. Allington et al.
FASEB JOURNAL (2009)
Mechanisms of the epithelial-mesenchymal transition by TGF-beta
Michael K. Wendt et al.
FUTURE ONCOLOGY (2009)
Epithelial-mesenchymal transition in development and cancer
Douglas S. Micalizzi et al.
FUTURE ONCOLOGY (2009)
Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells
Moses K. Donkor et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Peptide inhibitors of transforming growth factor-β enhance the efficacy of antitumor immunotherapy
Diana Llopiz et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
p130Cas Is Required for Mammary Tumor Growth and Transforming Growth Factor-β-mediated Metastasis through Regulation of Smad2/3 Activity
Michael K. Wendt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Abrogation of TGF-β signaling enhances chemokine production and correlates with prognosis in human breast cancer
Brian Bierie et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling
Douglas S. Micalizzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-beta 1
Hequan Li et al.
JOURNAL OF IMMUNOLOGY (2009)
Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells
Alessandra Cucina et al.
JOURNAL OF PINEAL RESEARCH (2009)
Dual effects of TGF-β on ERα-mediated estrogenic transcriptional activity in breast cancer
Yongsheng Ren et al.
MOLECULAR CANCER (2009)
Cathepsin G-Mediated Activation of Pro-Matrix Metalloproteinase 9 at the Tumor-Bone Interface Promotes Transforming Growth Factor-β Signaling and Bone Destruction
Thomas J. Wilson et al.
MOLECULAR CANCER RESEARCH (2009)
A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial-mesenchymal transition
Theresa Vincent et al.
NATURE CELL BIOLOGY (2009)
Multigene targeting of signal transduction pathways for the treatment of breast and prostate tumors
Marvin Rubenstein et al.
MEDICAL ONCOLOGY (2009)
BRCA1 Interacts with Smad3 and Regulates Smad3-Mediated TGF-β Signaling during Oxidative Stress Responses
Huchun Li et al.
PLOS ONE (2009)
Preclinical Efficacy of Cystatin C to Target the Oncogenic Activity of Transforming Growth Factor beta in Breast Cancer
Maozhen Tian et al.
TRANSLATIONAL ONCOLOGY (2009)
Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis
Michael K. Wendt et al.
BREAST CANCER RESEARCH (2009)
Knockdown of the transforming growth factor-β type III receptor impairs motility and invasion of metastatic cancer cells
Tracy L. Criswell et al.
CANCER RESEARCH (2008)
An anti-transforming growth factor β antibody suppresses metastasis via cooperative effects on multiple cell compartments
Jeong-Seok Nam et al.
CANCER RESEARCH (2008)
Transforming growth factor β subverts the immune system into directly promoting tumor growth through interleukin-17
Jeong-Seok Nam et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
TGF-beta signaling in neuronal stem cells
Chohee Yun et al.
DISEASE MARKERS (2008)
Transforming growth factor-beta signaling and ubiquitinators in cancer
Eric Glasgow et al.
ENDOCRINE-RELATED CANCER (2008)
Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-beta kinase antagonist, in mice
Lorea Bueno et al.
EUROPEAN JOURNAL OF CANCER (2008)
Neuropilin-1 is a receptor for transforming growth factor β-1, activates its latent form, and promotes regulatory T cell activity
Yelena Glinka et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA
William Kong et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab
Shizhen Emily Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Transforming Growth Factor-β Signaling-Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion
Nikki Cheng et al.
MOLECULAR CANCER RESEARCH (2008)
17-β-Estradiol Inhibits Transforming Growth Factor-β Signaling and Function in Breast Cancer Cells via Activation of Extracellular Signal-Regulated Kinase through the G Protein-Coupled Receptor 30
Burkhard Kleuser et al.
MOLECULAR PHARMACOLOGY (2008)
Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide;: a novel ALK5 inhibitor and a potential anti-fibrosis drug
Y. W. Kim et al.
XENOBIOTICA (2008)
Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells:: a population study
Theresa M. Casey et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Circulating transforming growth factor-β-1 and breast cancer prognosis:: results from the Shanghai Breast Cancer Study
Ana M. Grau et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk
Peter Broderick et al.
NATURE GENETICS (2007)
Targeting transforming growth factor-β signaling
Michael Pennison et al.
CURRENT OPINION IN ONCOLOGY (2007)
TGF-β and BMP7 interactions in tumour progression and bone metastasis
Jeroen T. Buijs et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
TGF-β signaling:: A tale of two responses
Rod A. Rahimi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Transforming growth factor-β can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model
Binwu Tang et al.
CANCER RESEARCH (2007)
A delicate balance:: TGF-β and the tumor microenvironment
Daniel G. Stover et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Differential intracellular signalling induced by TGF-β in rat adult hepatocytes and hepatoma cells:: Implications in liver carcinogenesis
Laia Caja et al.
CELLULAR SIGNALLING (2007)
Molecular definition of breast tumor heterogeneity
Michail Shipitsin et al.
CANCER CELL (2007)
Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line
Shogo Ehata et al.
CANCER SCIENCE (2007)
Smad4-independent TGF-beta signaling in tumor cell migration
Klaudia Giehl et al.
CELLS TISSUES ORGANS (2007)
Epithelial-mesenchymal transition and tumour invasion
Marcello Guarino
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Regulation of Smad activities
Lan Xu
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2006)
TGF-β in cancer and as a therapeutic target
Jan Pinkas et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-β type I receptor kinase inhibitor
Abhik Bandyopadhyay et al.
CANCER RESEARCH (2006)
Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor β in a mouse model of breast cancer
Jeong-Seok Nam et al.
CANCER RESEARCH (2006)
Autocrine PDGFR signaling promotes mammary cancer metastasis
Martin Jechlinger et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Transforming growth factor-beta in cancer and metastasis
Sonia B. Jakowlew
CANCER AND METASTASIS REVIEWS (2006)
Latent transforming growth factor-β (TGF-β) binding proteins:: Orchestrators of TGF-β availability
DB Rifkin
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Transforming growth factor-β-related proteins:: an ancestral and widespread superfamily of cytokines in metazoans
A Herpin et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
BW Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-b receptor exhibit impaired mammary development and enhanced mammary tumor formation
AE Gorska et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis
PM Siegel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Minimal effects on immune parameters following chronic anti-TGF-beta monoclonal antibody administration to normal mice
MC Ruzek et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2003)
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
YA Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B)
XH Feng et al.
MOLECULAR CELL (2002)
Induction of angiogenesis by expression of soluble type II transforming growth factor-β receptor in mouse hepatoma
KY Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transcriptional control by the TGF-β/Smad signaling system
J Massagué et al.
EMBO JOURNAL (2000)
Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
L Gorelik et al.
IMMUNITY (2000)
Share Paper
